1 (Image 1)
This text is not available for evaluation as it is very short and does not convey any meaning or context for generating a useful description.*
Mesalamine Capsule, Delayed Release
Product Images NDC 0093-5907
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0093-5907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This text is the description and instructions for use of a medication in capsule form containing 100mg of mesatamine. The medication is to be stored between 20-25°C and dispensed in a light-resistant container with a closure. It can be taken with or without food. The text also includes the manufacturer's information and trademark disclaimer. The product is serialized with the GTIN 0030935907864 and the NDC 0093-5907-86.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
